MicroPort (微创医疗机器人, HK: 02252), a Shanghai-based surgical robot giant, recently has deployed its robot to take part in what it said is Europe’s first Total Knee Arthroplasty (TKA) in Greece.
MedBot, which was developed by a Suzhou subsidiary of the Shanghai medtech group, completed three surgical procedures within the same day on September 5 to replace the knees of patients at the University General Hospital of Larissa, a city in Greece.
According to an official statement released by MicroPort, the robot-assisted surgeries in Greece represented a key milestone in the company’s quest to explore the European market.
Its expansion into Europe followed the acquisition of a FDA certificate in August last year for its MedBot system, clearing the way for it to enter the US market, home to industrial pioneers like Intuitive Surgical’s da Vinci system.
MicroPort claims that the application of MedBot in Europe is conducive to the firm’s strategy to go global.
It looks to benefit more patients worldwide with cutting-edge Chinese technologies, in a bid to realize the intentions of “leaving the world with no difficult surgery to perform.”
